Generation of NK cells with chimeric-switch receptors to overcome PD1-mediated inhibition in cancer immunotherapy.

Cancer Immunol Immunother · 2023 · PMC10110653 · PMID 36355079

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

highly significantno p-value reported

p < 0.05 was determined as statistically significant (*), p < 0.01 (**), p < 0.001 (***), p < 0.0001 (****) as statistically highly significant.

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.